Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Paroxetine steady-state plasma concentration in relation to CYP2D6 genotype in extensive metabolizers.

Journal of clinical psychopharmacology - 1 Oct 1999

Ozdemir V, Tyndale R F, Reed K, Herrmann N, Sellers E M, Kalow W, Naranjo C A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents, Second-Generation
Share to Cytochrome P-450 CYP2D6
Share to Genotype
Share to Paroxetine

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10505591
DOI: 10.1097/00004714-199910000-00014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Paroxetine steady-state plasma concentration in relation to CYP2D6 genotype in extensive metabolizers.PMID 10505591Read ↗

Low serum concentrations of paroxetine in CYP2D6 ultrarapid metabolizers.Semantic proximity Read ↗

Impact of CYP2D6 Genotype on Paroxetine Serum Concentration.Semantic proximity Read ↗

CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response.Semantic proximity Read ↗

Dose adjustment of paroxetine based on CYP2D6 activity score inferred metabolizer status in Chinese Han patients with depressive or anxiety disorders: a prospective study and cross-ethnic meta-analysis.Semantic proximity Read ↗

Precision dosing-based optimisation of paroxetine during pregnancy for poor and ultrarapid CYP2D6 metabolisers: a virtual clinical trial pharmacokinetics study.Semantic proximity Read ↗

Effects of paroxetine on the pharmacokinetics of atomoxetine and its metabolites in different CYP2D6 genotypes.Semantic proximity Read ↗

Polymorphisms in the CYP 2D6 gene: association with plasma concentrations of fluoxetine and paroxetine.Semantic proximity Read ↗

Effect of cytochrome P450 2D6 genotype on maternal paroxetine plasma concentrations during pregnancy.Semantic proximity Read ↗

Impact of CYP2D6 Functional Allelic Variations on Phenoconversion and Drug-Drug Interactions.Semantic proximity Read ↗

Association between CYP2D6 genotype and vortioxetine exposure and therapeutic failure - a retrospective, cohort studySemantic proximity Read ↗

Links among paroxetine-induced sexual dysfunctions, gender, and CYP2D6 activity.Semantic proximity Read ↗

Relationship of CYP2D6, CYP3A, POR, and ABCB1 genotypes with galantamine plasma concentrations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.